Search
for
Sort by
Research 31–60 of 105
- A symphony of signals: the intricate role of lncRNAs in dermatological disorders
- Geranyl Acetate Attenuates Para-phenylenediamine-induced Cytotoxicity, DNA Damage, Apoptosis, and Inflammation in HaCaT Keratinocytes
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Graft-versus-host disease with acute hair loss: A distinctive manifestation of chronic graft-versus-host disease
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Hair Changes due to Drugs
- Poster Abstracts
- Table of Contents
- Index
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
- Hidradenitis secondary to nirogacestat, a recently approved desmoid tumor medication
- Melanotic pigmentation in excisional scar of melanoma patient who received BRAF and MEK inhibitors
- RAGE and Its Ligands in Melanoma
- Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis
- Hypogonadism as a Reversible Cause of Torsades de Pointes in Men
- Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis
- The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B‐rapidly accelerated fibrosarcoma‐mutated advanced melanoma
- Advantages of Functional Foods in Supporting and Maintaining Hair and Skin Health
- Successfully Nonsurgical Epidermoid Cyst Management with Recombinant Hydrolytic Enzymes: A Case Report
- Alopecia due to chemotherapeutics, hedgehog inhibitors, targeted antibody therapies and immune checkpoint inhibitors
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Polymeric nanoparticles‐based topical delivery systems for the treatment of dermatological diseases
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- A novel mouse model demonstrates that oncogenic melanocyte stem cells engender melanoma resembling human disease